{
    "2018-09-27": [
        [
            {
                "time": "2018-09-27",
                "original_text": "医药股集体大涨 机构揭秘打好四季度“反击战”的三条思路",
                "features": {
                    "keywords": [
                        "医药股",
                        "集体大涨",
                        "机构",
                        "四季度",
                        "反击战",
                        "三条思路"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "财经汇·早间必读 | 20180927",
                "features": {
                    "keywords": [
                        "财经汇",
                        "早间必读"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "医药行业向来是一片创新研发“沃土” 医药板块未来可期",
                "features": {
                    "keywords": [
                        "医药行业",
                        "创新研发",
                        "沃土",
                        "医药板块",
                        "未来可期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "医药创新再迎政策激励 7只低估值业绩预喜股潜力足",
                "features": {
                    "keywords": [
                        "医药创新",
                        "政策激励",
                        "低估值",
                        "业绩预喜",
                        "潜力足"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}